• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粘性放线菌T14V与血链球菌34之间共聚集的抑制剂:β-半乳糖苷、相关糖类及阴离子两亲性化合物

Inhibitors of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34: beta-galactosides, related sugars, and anionic amphipathic compounds.

作者信息

McIntire F C, Crosby L K, Vatter A E

出版信息

Infect Immun. 1982 Apr;36(1):371-8. doi: 10.1128/iai.36.1.371-378.1982.

DOI:10.1128/iai.36.1.371-378.1982
PMID:7076303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC351228/
Abstract

Coaggregation between Actinomyces viscosus T14V (T14V) and Streptococcus sanguis 34 (Ss34) depends upon specific reaction between lectin on T14V and carbohydrate on Ss34. Studies on coaggregation inhibition by sugars related to D-galactose, beta-galactosides, and amphipathic molecules revealed: (i) D-fucose, D-talose approximately equal to D-galactose, which was 0.2 potency of lactose. No other hexoses or pentoses inhibited at 0.1 M. (ii) Gal beta (1 leads to 3)GalNAc alpha OCH2C6H5 was the most potent beta-galactoside inhibitor; it had 20 times the potency of lactose. (iii) Anionic nonaromatic amphipathic compounds were good inhibitors; sodium deoxycholate (I) was equal to lactose; sodium dodecyl sulfate (II) had 15 times the potency of lactose; there was 90 to 100% irreversible inhibition when T14V was treated with 0.005 M (II). Treatment of Ss34 with II had no effect. (iv) Synergism of inhibition was observed between lactose and I or lactose and II, e.g., inhibition by 0.01 M lactose = 5%; inhibition by 0.01 M I = 9%; inhibition by 0.01 M lactose + 0.01 M I = 87%. (v) The irreversible inhibition by II was prevented when 0.25 M lactose or 0.25 M I was present during treatment of T14V with 0.005 M II. (vi) Synergism and prevention by lactose or by I of irreversible inhibition by II suggest that all three react at the same site on T14V lectin. We hypothesize that the T14V lectin combining site for Ss34 carbohydrate has specific affinity for beta-galactosides and for anionic nonaromatic amphipathic molecules. This site can be saturated by either kind of reagent to exclude the other reagent or to inhibit coaggregation.

摘要

黏性放线菌T14V(T14V)与血链球菌34(Ss34)之间的共聚作用取决于T14V上的凝集素与Ss34上的碳水化合物之间的特异性反应。对与D - 半乳糖、β - 半乳糖苷和两亲性分子相关的糖类对共聚作用的抑制研究表明:(i)D - 岩藻糖、D - 塔罗糖对共聚作用的抑制效果与D - 半乳糖相近,其抑制效力为乳糖的0.2倍。在0.1 M浓度下,其他己糖或戊糖均无抑制作用。(ii)Galβ(1→3)GalNAcαOCH2C6H5是最有效的β - 半乳糖苷抑制剂;其效力为乳糖的20倍。(iii)阴离子非芳香族两亲性化合物是良好的抑制剂;脱氧胆酸钠(I)的抑制效果与乳糖相当;十二烷基硫酸钠(II)的效力为乳糖的15倍;当用0.005 M(II)处理T14V时,存在90%至100%的不可逆抑制作用。用(II)处理Ss34则无效果。(iv)在乳糖与(I)或乳糖与(II)之间观察到抑制作用的协同效应,例如,0.01 M乳糖的抑制率为5%;0.01 M(I)的抑制率为9%;0.01 M乳糖 + 0.01 M(I)的抑制率为87%。(v)当在0.005 M(II)处理T14V的过程中存在0.25 M乳糖或0.25 M(I)时,可防止(II)的不可逆抑制作用。(vi)乳糖或(I)对(II)的不可逆抑制作用的协同效应及防止作用表明,这三种物质均在T14V凝集素的同一部位发生反应。我们推测,T14V凝集素与Ss34碳水化合物的结合位点对β - 半乳糖苷和阴离子非芳香族两亲性分子具有特异性亲和力。该位点可被任何一种试剂饱和,从而排除另一种试剂或抑制共聚作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5892/351228/98d94eb3dfe5/iai00151-0386-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5892/351228/98d94eb3dfe5/iai00151-0386-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5892/351228/98d94eb3dfe5/iai00151-0386-a.jpg

相似文献

1
Inhibitors of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34: beta-galactosides, related sugars, and anionic amphipathic compounds.粘性放线菌T14V与血链球菌34之间共聚集的抑制剂:β-半乳糖苷、相关糖类及阴离子两亲性化合物
Infect Immun. 1982 Apr;36(1):371-8. doi: 10.1128/iai.36.1.371-378.1982.
2
Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.粘性放线菌T14V与血链球菌34之间的共聚机制。
Infect Immun. 1978 Sep;21(3):978-88. doi: 10.1128/iai.21.3.978-988.1978.
3
A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.来自粘性放线菌T14V的一种可特异性凝集血链球菌H1的因子。
Infect Immun. 1983 Jun;40(3):1204-13. doi: 10.1128/iai.40.3.1204-1213.1983.
4
A polysaccharide from Streptococcus sanguis 34 that inhibits coaggregation of S. sanguis 34 with Actinomyces viscosus T14V.一种来自血链球菌34的多糖,可抑制血链球菌34与粘性放线菌T14V的共聚。
J Bacteriol. 1988 May;170(5):2229-35. doi: 10.1128/jb.170.5.2229-2235.1988.
5
Structural preferences of beta-galactoside-reactive lectins on Actinomyces viscosus T14V and Actinomyces naeslundii WVU45.β-半乳糖苷反应性凝集素对粘性放线菌T14V和内氏放线菌WVU45的结构偏好性
Infect Immun. 1983 Aug;41(2):848-50. doi: 10.1128/iai.41.2.848-850.1983.
6
Kinetics of lactose-reversible coadhesion of Actinomyces naeslundii WVU 398A and Streptococcus oralis 34 on the surface of hexadecane droplets.内氏放线菌WVU 398A和口腔链球菌34在十六烷微滴表面乳糖可逆性共聚黏附的动力学
Oral Microbiol Immunol. 1994 Dec;9(6):364-71. doi: 10.1111/j.1399-302x.1994.tb00287.x.
7
Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis.粘性放线菌、内氏放线菌和血链球菌共聚集缺陷突变体的分离与鉴定
Infect Immun. 1982 Sep;37(3):1200-8. doi: 10.1128/iai.37.3.1200-1208.1982.
8
Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii.人类口腔链球菌与粘性放线菌或内氏放线菌菌株之间共聚集反应的特异性。
Infect Immun. 1979 Jun;24(3):742-52. doi: 10.1128/iai.24.3.742-752.1979.
9
Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.粘性放线菌口腔表面定植中细菌相互作用的作用。
Infect Immun. 1980 Jul;29(1):83-90. doi: 10.1128/iai.29.1.83-90.1980.
10
Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.黏性放线菌t14v的菌毛:它们与毒力相关抗原以及与血链球菌34共聚集的关系。
Adv Exp Med Biol. 1978;107:695-701. doi: 10.1007/978-1-4684-3369-2_78.

引用本文的文献

1
Comparative evaluation of effect of nisin-incorporated ethylenediamine tetraacetic acid and MTAD on endodontic biofilm eradication, smear layer removal, and depth of sealer penetration.尼生素结合乙二胺四乙酸与 MTAD 对根管生物膜清除、玷污层去除及封闭剂渗透深度效果的比较评价。
Clin Oral Investig. 2023 Dec;27(12):7247-7259. doi: 10.1007/s00784-023-05285-8. Epub 2023 Nov 24.
2
Glycan recognition at the saliva - oral microbiome interface.聚糖在唾液-口腔微生物组界面的识别。
Cell Immunol. 2018 Nov;333:19-33. doi: 10.1016/j.cellimm.2018.08.008. Epub 2018 Aug 18.
3
A specific cell surface antigen of Streptococcus gordonii is associated with bacterial hemagglutination and adhesion to alpha2-3-linked sialic acid-containing receptors.

本文引用的文献

1
Isolation of D-talomethylose (6-deoxy-Dtalose) and D-rhamnose (6-deoxy-D-mannose) from capsular polysaccharide of a gram-negative bacterium.从一种革兰氏阴性细菌的荚膜多糖中分离出D-塔罗甲基糖(6-脱氧-D-塔罗糖)和D-鼠李糖(6-脱氧-D-甘露糖)。
J Biol Chem. 1962 Jun;237:1767-71.
2
Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.利用单克隆抗体检测和定位粘性放线菌T14V上的一种凝集素。
J Immunol. 1981 Oct;127(4):1318-22.
3
Interbacterial aggregation of plaque bacteria.菌斑细菌的菌间聚集。
戈登链球菌的一种特定细胞表面抗原与细菌血凝作用以及与含α2-3连接唾液酸的受体的黏附相关。
Infect Immun. 1997 Dec;65(12):5042-51. doi: 10.1128/iai.65.12.5042-5051.1997.
4
Structural and antigenic types of cell wall polysaccharides from viridans group streptococci with receptors for oral actinomyces and streptococcal lectins.来自草绿色链球菌的细胞壁多糖的结构和抗原类型,其具有针对口腔放线菌和链球菌凝集素的受体
Infect Immun. 1997 Dec;65(12):5035-41. doi: 10.1128/iai.65.12.5035-5041.1997.
5
Significance of bacterial surface-active compounds in interaction of bacteria with interfaces.细菌表面活性化合物在细菌与界面相互作用中的意义。
Microbiol Rev. 1996 Mar;60(1):151-66. doi: 10.1128/mr.60.1.151-166.1996.
6
Specific coaggregation and the cell wall of Streptococcus sanguis.血链球菌的特异性共聚作用与细胞壁
J Bacteriol. 1983 Aug;155(2):896-9. doi: 10.1128/jb.155.2.896-899.1983.
7
Structural preferences of beta-galactoside-reactive lectins on Actinomyces viscosus T14V and Actinomyces naeslundii WVU45.β-半乳糖苷反应性凝集素对粘性放线菌T14V和内氏放线菌WVU45的结构偏好性
Infect Immun. 1983 Aug;41(2):848-50. doi: 10.1128/iai.41.2.848-850.1983.
8
Interbacterial adherence between Actinomyces viscosus and strains of Streptococcus pyogenes, Streptococcus agalactiae, and Pseudomonas aeruginosa.黏性放线菌与化脓性链球菌、无乳链球菌及铜绿假单胞菌菌株之间的菌间黏附。
Infect Immun. 1984 Apr;44(1):86-90. doi: 10.1128/iai.44.1.86-90.1984.
9
A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.来自粘性放线菌T14V的一种可特异性凝集血链球菌H1的因子。
Infect Immun. 1983 Jun;40(3):1204-13. doi: 10.1128/iai.40.3.1204-1213.1983.
10
Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.在具核放线菌的典型菌株(WVU45)上乳糖敏感菌毛的独特存在。
Infect Immun. 1984 Nov;46(2):453-8. doi: 10.1128/iai.46.2.453-458.1984.
Arch Oral Biol. 1970 Dec;15(12):1397-400. doi: 10.1016/0003-9969(70)90031-2.
4
Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii.人类口腔链球菌与粘性放线菌或内氏放线菌菌株之间共聚集反应的特异性。
Infect Immun. 1979 Jun;24(3):742-52. doi: 10.1128/iai.24.3.742-752.1979.
5
Compounds which affect the adherence of Streptococcus sanguis and Streptococcus mutans to hydroxyapatite.影响血链球菌和变形链球菌对羟基磷灰石黏附的化合物。
J Dent Res. 1978 Feb;57(2):373-9. doi: 10.1177/00220345780570023901.
6
Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.粘性放线菌T14V与血链球菌34之间的共聚机制。
Infect Immun. 1978 Sep;21(3):978-88. doi: 10.1128/iai.21.3.978-988.1978.